The diagnostic significance of trophoblast cell-surface antigen-2 expression in benign and malignant thyroid lesions

Context: Thyroid cancers are the most common malignancy of the endocrine system. Over-expression of trophoblast cell-surface antigen 2 (TROP-2) in various tumors has been found to correlate with poor prognosis and aggressive tumor behavior. Aims: The aim of this study was to evaluateTROP-2 expressio...

Full description

Bibliographic Details
Main Authors: Canan Sadullahoğlu, Alper Sayıner, Dinç Süren, Hülya Tosun Yıldırım, Döndü Nergiz, Cem Sezer, Mehmet Tahir Oruç
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2019;volume=62;issue=2;spage=206;epage=210;aulast=Sadullahoğlu
_version_ 1819274616036655104
author Canan Sadullahoğlu
Alper Sayıner
Dinç Süren
Hülya Tosun Yıldırım
Döndü Nergiz
Cem Sezer
Mehmet Tahir Oruç
author_facet Canan Sadullahoğlu
Alper Sayıner
Dinç Süren
Hülya Tosun Yıldırım
Döndü Nergiz
Cem Sezer
Mehmet Tahir Oruç
author_sort Canan Sadullahoğlu
collection DOAJ
description Context: Thyroid cancers are the most common malignancy of the endocrine system. Over-expression of trophoblast cell-surface antigen 2 (TROP-2) in various tumors has been found to correlate with poor prognosis and aggressive tumor behavior. Aims: The aim of this study was to evaluateTROP-2 expression in thyroid neoplasms. Subjects and Methods: This study contained 152 cases, including 48 follicular nodular disease (FND), 29 follicular adenoma (FA), 57 papillary thyroid carcinoma (PTC), 12 follicular thyroid carcinoma (FTC), 3 medullary thyroid carcinoma (MTC), 2 poorly differentiated thyroid carcinoma (PDTC) and 1 undifferentiated thyroid carcinoma (UDTC). TROP-2 expression was investigated via immunohistochemistry in sections prepared from paraffin blocks of the cases. Results: The cases comprised 32 (21%) males and 120 (79%) females with a mean age of 46.8 years (range, 15-85 years). TROP-2 expression was observed in 74.6% of the malignant lesions of the thyroid except for medullary carcinoma, poorly differentiated and undifferentiated thyroid carcinoma. Immunoreactivity was 3.4% in FA, 41.7% of cases with FTC and 81.8% in PTC follicular variant (PTC fv). The difference between FA/FTC and FA/PTC follicular variant were both significant (P < 0.005, P < 0.001, respectively). There was no difference between FTC/PTC fv (P = 0.089). Conclusion: TROP-2 can be considered a useful marker for distinguishing PTC fv cases from follicular nodular disease and follicular adenoma cases because of its high sensitivity in the identification of papillary carcinomas of the thyroid.
first_indexed 2024-12-23T23:11:15Z
format Article
id doaj.art-4b091890f73f42b9b6dcdb3f04e27dc8
institution Directory Open Access Journal
issn 0377-4929
language English
last_indexed 2024-12-23T23:11:15Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Pathology and Microbiology
spelling doaj.art-4b091890f73f42b9b6dcdb3f04e27dc82022-12-21T17:26:39ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292019-01-0162220621010.4103/IJPM.IJPM_202_18The diagnostic significance of trophoblast cell-surface antigen-2 expression in benign and malignant thyroid lesionsCanan SadullahoğluAlper SayınerDinç SürenHülya Tosun YıldırımDöndü NergizCem SezerMehmet Tahir OruçContext: Thyroid cancers are the most common malignancy of the endocrine system. Over-expression of trophoblast cell-surface antigen 2 (TROP-2) in various tumors has been found to correlate with poor prognosis and aggressive tumor behavior. Aims: The aim of this study was to evaluateTROP-2 expression in thyroid neoplasms. Subjects and Methods: This study contained 152 cases, including 48 follicular nodular disease (FND), 29 follicular adenoma (FA), 57 papillary thyroid carcinoma (PTC), 12 follicular thyroid carcinoma (FTC), 3 medullary thyroid carcinoma (MTC), 2 poorly differentiated thyroid carcinoma (PDTC) and 1 undifferentiated thyroid carcinoma (UDTC). TROP-2 expression was investigated via immunohistochemistry in sections prepared from paraffin blocks of the cases. Results: The cases comprised 32 (21%) males and 120 (79%) females with a mean age of 46.8 years (range, 15-85 years). TROP-2 expression was observed in 74.6% of the malignant lesions of the thyroid except for medullary carcinoma, poorly differentiated and undifferentiated thyroid carcinoma. Immunoreactivity was 3.4% in FA, 41.7% of cases with FTC and 81.8% in PTC follicular variant (PTC fv). The difference between FA/FTC and FA/PTC follicular variant were both significant (P < 0.005, P < 0.001, respectively). There was no difference between FTC/PTC fv (P = 0.089). Conclusion: TROP-2 can be considered a useful marker for distinguishing PTC fv cases from follicular nodular disease and follicular adenoma cases because of its high sensitivity in the identification of papillary carcinomas of the thyroid.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2019;volume=62;issue=2;spage=206;epage=210;aulast=SadullahoğluFollicular neoplasmthyroid carcinomaTROP-2
spellingShingle Canan Sadullahoğlu
Alper Sayıner
Dinç Süren
Hülya Tosun Yıldırım
Döndü Nergiz
Cem Sezer
Mehmet Tahir Oruç
The diagnostic significance of trophoblast cell-surface antigen-2 expression in benign and malignant thyroid lesions
Indian Journal of Pathology and Microbiology
Follicular neoplasm
thyroid carcinoma
TROP-2
title The diagnostic significance of trophoblast cell-surface antigen-2 expression in benign and malignant thyroid lesions
title_full The diagnostic significance of trophoblast cell-surface antigen-2 expression in benign and malignant thyroid lesions
title_fullStr The diagnostic significance of trophoblast cell-surface antigen-2 expression in benign and malignant thyroid lesions
title_full_unstemmed The diagnostic significance of trophoblast cell-surface antigen-2 expression in benign and malignant thyroid lesions
title_short The diagnostic significance of trophoblast cell-surface antigen-2 expression in benign and malignant thyroid lesions
title_sort diagnostic significance of trophoblast cell surface antigen 2 expression in benign and malignant thyroid lesions
topic Follicular neoplasm
thyroid carcinoma
TROP-2
url http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2019;volume=62;issue=2;spage=206;epage=210;aulast=Sadullahoğlu
work_keys_str_mv AT canansadullahoglu thediagnosticsignificanceoftrophoblastcellsurfaceantigen2expressioninbenignandmalignantthyroidlesions
AT alpersayıner thediagnosticsignificanceoftrophoblastcellsurfaceantigen2expressioninbenignandmalignantthyroidlesions
AT dincsuren thediagnosticsignificanceoftrophoblastcellsurfaceantigen2expressioninbenignandmalignantthyroidlesions
AT hulyatosunyıldırım thediagnosticsignificanceoftrophoblastcellsurfaceantigen2expressioninbenignandmalignantthyroidlesions
AT dondunergiz thediagnosticsignificanceoftrophoblastcellsurfaceantigen2expressioninbenignandmalignantthyroidlesions
AT cemsezer thediagnosticsignificanceoftrophoblastcellsurfaceantigen2expressioninbenignandmalignantthyroidlesions
AT mehmettahiroruc thediagnosticsignificanceoftrophoblastcellsurfaceantigen2expressioninbenignandmalignantthyroidlesions
AT canansadullahoglu diagnosticsignificanceoftrophoblastcellsurfaceantigen2expressioninbenignandmalignantthyroidlesions
AT alpersayıner diagnosticsignificanceoftrophoblastcellsurfaceantigen2expressioninbenignandmalignantthyroidlesions
AT dincsuren diagnosticsignificanceoftrophoblastcellsurfaceantigen2expressioninbenignandmalignantthyroidlesions
AT hulyatosunyıldırım diagnosticsignificanceoftrophoblastcellsurfaceantigen2expressioninbenignandmalignantthyroidlesions
AT dondunergiz diagnosticsignificanceoftrophoblastcellsurfaceantigen2expressioninbenignandmalignantthyroidlesions
AT cemsezer diagnosticsignificanceoftrophoblastcellsurfaceantigen2expressioninbenignandmalignantthyroidlesions
AT mehmettahiroruc diagnosticsignificanceoftrophoblastcellsurfaceantigen2expressioninbenignandmalignantthyroidlesions